May 2009

May 31

Bayer plc
Sun shines on Bayer Newbury 10K
David Fry, from Newbury Athletic Club, won the annual Bayer Newbury 10K for the second time in 35 minutes 40 seconds, just over his 35 minutes and six seconds time set last year. » more

May 26

Bayer AG
Sustainable Development Report 2008 published
Investment in the future: R&D budget of EUR 2.9 billion. Contributing solutions to global challenges: Global access to medicines, feeding the world population, water protection, climate change. Intensive social commitment: EUR 50 million for education, social needs, environmental protection, culture and sports » more

May 19

Bayer Schering Pharma
Bayer Schering Pharma presents positive results of phase II study with Riociguat
Positive data from a phase II trial with Bayer Schering Pharma’s oral agent riociguat for the treatment of two different forms of pulmonary hypertension (PH); chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH); were presented today at the American Thoracic Society (ATS) international conference in San Diego, USA. » more

May 12

Bayer AG
"Corporate strategy proves effective in a difficult environment"
Werner Wenning at the Bayer AG Annual Stockholders' Meeting - Earnings targets met in 2008 / Proposed 3.7 percent increase in dividend, to EUR 1.40 per share / CropScience and Pharmaceuticals remain on a path of growth in the current year / Group targets increasingly demanding following the slump in business at MaterialScience » more